RESUMEN
Dyke-Davidoff-Masson Syndrome (DDMS) is a rare condition usually diagnosed in paediatric patients with clinical features of hemiparesis, seizures, mental retardation and contralateral cerebral hemiatrophy on neuroimaging. This report follows the case of a 22-year-old man presenting with seizures and hemiatrophy and hemiparesis. On review of cases the most common neuroimaging findings were cerebral hemiatrophy (100%) followed by hemicalvarial thickening (71.4%) and hyperpneumatisation of sinuses (71.4%). Apart from our patient, all nine cases with data on epilepsy control had drug-resistant epilepsy. The onset of seizures in adulthood, block vertebra, short stature, absence of mental retardation and well-controlled epilepsy on monotherapy makes our case exceptional-even bringing to mind the possibility of a DDMS variant. This report exhaustively reviews the wide range of clinical and radiological manifestations of DDMS in the adult, thereby adding to the literature on an unusual syndrome that causes significant neurological morbidity.
Asunto(s)
Encéfalo/patología , Epilepsia Tónico-Clónica/diagnóstico , Hemiplejía/diagnóstico , Paresia/diagnóstico , Atrofia/complicaciones , Atrofia/diagnóstico por imagen , Atrofia/patología , Encéfalo/diagnóstico por imagen , Epilepsia Tónico-Clónica/etiología , Humanos , Discapacidad Intelectual/diagnóstico , Imagen por Resonancia Magnética , Masculino , Síndrome , Vértebras Torácicas/diagnóstico por imagen , Adulto JovenRESUMEN
The 2001 classification subcommittee of the International League Against Epilepsy (ILAE) proposed to 'group JME, juvenile absence epilepsy, and epilepsy with tonic clonic seizures only under the sole heading of idiopathic generalized epilepsies (IGE) with variable phenotype'. The implication is that juvenile myoclonic epilepsy (JME) does not exist as the sole phenotype of family members and that it should no longer be classified by itself or considered a distinct disease entity. Although recognized as a common form of epilepsy and presumed to be a lifelong trait, a long-term follow-up of JME has not been performed. To address these two issues, we studied 257 prospectively ascertained JME patients and encountered four groups: (i) classic JME (72%), (ii) CAE (childhood absence epilepsy) evolving to JME (18%), (iii) JME with adolescent absence (7%), and (iv) JME with astatic seizures (3%). We examined clinical and EEG phenotypes of family members and assessed clinical course over a mean of 11 +/- 6 years and as long as 52 years. Forty per cent of JME families had JME as their sole clinical phenotype. Amongst relatives of classic JME families, JME was most common (40%) followed by grand mal (GM) only (35%). In contrast, 66% of families with CAE evolving to JME expressed the various phenotypes of IGE in family members. Absence seizures were more common in family members of CAE evolving to JME than in those of classic JME families (P < 0.001). Female preponderance, maternal transmission and poor response to treatment further characterized CAE evolving to JME. Only 7% of those with CAE evolving to JME were seizure-free compared with 58% of those with classic JME (P < 0.001), 56% with JME plus adolescent pyknoleptic absence and 62% with JME plus astatic seizures. Long-term follow-up (1-40 years for classic JME; 5-52 years for CAE evolving to JME, 5-26 years for JME with adolescent absence and 3-18 years for JME with astatic seizures) indicates that all subsyndromes are chronic and perhaps lifelong. Seven chromosome loci, three epilepsy-causing mutations and two genes with single nucleotide polymorphisms (SNPs) associating with JME reported in literature provide further evidence for JME as a distinct group of diseases.
Asunto(s)
Epilepsia Mioclónica Juvenil/genética , Adolescente , Adulto , Edad de Inicio , Niño , Enfermedad Crónica , Progresión de la Enfermedad , Electroencefalografía , Familia , Femenino , Estudios de Seguimiento , Humanos , Masculino , Epilepsia Mioclónica Juvenil/clasificación , Fenotipo , Polimorfismo de Nucleótido Simple , Pronóstico , Factores SexualesRESUMEN
Idiopathic generalized epilepsies (IGEs) comprise at least 40% of epilepsies in the United States, 20% in Mexico, and 8% in Central America. Here, we review seizure phenotypes across IGE syndromes, their response to treatment and advances in molecular genetics that influence nosology. Our review included the Medline database from 1945 to 2005 and our prospectively collected Genetic Epilepsy Studies (GENESS) Consortium database. Generalized seizures occur with different and similar semiologies, frequencies, and patterns, ages at onset, and outcomes in different IGEs, suggesting common neuroanatomical pathways for seizure phenotypes. However, the same seizure phenotypes respond differently to the same treatments in different IGEs, suggesting different molecular defects across syndromes. De novo mutations in SCN1A in sporadic Dravet syndrome and germline mutations in SCN1A, SCN1B, and SCN2A in generalized epilepsies with febrile seizures plus have unraveled the heterogenous myoclonic epilepsies of infancy and early childhood. Mutations in GABRA1, GABRG2, and GABRB3 are associated with absence seizures, while mutations in CLCN2 and myoclonin/EFHC1 substantiate juvenile myoclonic epilepsy as a clinical entity. Refined understanding of seizure phenotypes, their semiology, frequencies, and patterns together with the identification of molecular lesions in IGEs continue to accelerate the development of molecular epileptology.
Asunto(s)
Epilepsia Generalizada/clasificación , Epilepsia Generalizada/genética , Adolescente , Adulto , Distribución por Edad , Anticonvulsivantes/uso terapéutico , Niño , Preescolar , Epilepsia Generalizada/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Biología Molecular , Mutación/genética , Fenotipo , Pronóstico , SíndromeAsunto(s)
Epilepsia Tipo Ausencia/complicaciones , Salud de la Familia , Epilepsia Mioclónica Juvenil/etiología , Adolescente , Adulto , Edad de Inicio , Niño , Preescolar , Diagnóstico por Imagen , Electroencefalografía/métodos , Epilepsia Tipo Ausencia/genética , Femenino , Humanos , Lactante , Escala de Lod , Masculino , Epilepsia Mioclónica Juvenil/genética , Examen Neurológico , RiesgoAsunto(s)
Salud de la Familia , Epilepsia Mioclónica Juvenil/genética , Adolescente , Adulto , Edad de Inicio , Mapeo Cromosómico/métodos , Demografía , Electroencefalografía/métodos , Epilepsia/complicaciones , Epilepsia Tipo Ausencia/complicaciones , Epilepsia Tipo Ausencia/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Epilepsia Mioclónica Juvenil/clasificación , Epilepsia Mioclónica Juvenil/etiología , Fenotipo , Riesgo , Factores SexualesAsunto(s)
Anticonvulsivantes/uso terapéutico , Epilepsias Mioclónicas/tratamiento farmacológico , Epilepsia Mioclónica Juvenil/tratamiento farmacológico , Adolescente , Adulto , Algoritmos , Niño , Preescolar , Interacciones Farmacológicas , Quimioterapia Combinada , Epilepsias Mioclónicas/clasificación , Epilepsias Mioclónicas/complicaciones , Femenino , Estudios de Seguimiento , Humanos , Lactante , Estudios Longitudinales , Masculino , Epilepsia Mioclónica Juvenil/clasificación , Epilepsia Mioclónica Juvenil/etiología , Calidad de Vida , Literatura de Revisión como Asunto , Factores de Riesgo , Convulsiones/tratamiento farmacológico , Resultado del TratamientoRESUMEN
Understanding the latest advances in the molecular genetics of the epilepsies is important, as it provides a basis for comprehending the new practice of epileptology. Epilepsies have traditionally been classified and subtyped on the basis of clinical and neurophysiologic concepts. However, the complexity and variability of phenotypes and overlapping clinical features limit the resolution of phenotype-based classification and confound epilepsy nosology. Identification of tightly linked epilepsy DNA markers and discovery of epilepsy-causing mutations provide a basis for refining the classification of epilepsies. Recent discoveries regarding the genetics surrounding certain epilepsy types (including Lafora's progressive myoclonic epilepsy, the severe myoclonic epilepsy of infancy of Dravet, and idiopathic generalized epilepsies) may be the beginning of a better understanding of how rare Mendelian epilepsy genes and their genetic architecture can explain some complexities of the common epilepsies.